المؤلفون: Liao YC, Ying HQ, Huang Y, Luo YR, Xiong CF, Nie RW, Li XJ, Cheng XX

المصدر: Cancer Management and Research, Vol Volume 13, Pp 3455-3464 (2021)

مصطلحات موضوعية: mucinous colorectal carcinoma, fibrinogen-to-pre-albumin ratio, prognosis, inflammation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/role-of-chronic-inflammatory-ratios-in-predicting-recurrence-of-resect-peer-reviewed-fulltext-article-CMAR; https://doaj.org/toc/1179-1322

URL الوصول: https://doaj.org/article/1fdeba5ccb7e4198a58daee726468173

المؤلفون: Ying HQ; Department of Nuclear Medicine, Jiangxi Province Key Laboratory of Laboratory Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China., Liao YC; Biological Resource Center, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China; Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University, Nanchang 330006, China., Luo YR; Jiangxi Medical College, Nanchang University, Nanchang 330006, China., Xiong G; Department of Information, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China., Huang Y; Jiangxi Medical College, Nanchang University, Nanchang 330006, China., Nie RW; Jiangxi Medical College, Nanchang University, Nanchang 330006, China., Xiong CF; Jiangxi Medical College, Nanchang University, Nanchang 330006, China., Cheng XX; Biological Resource Center, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China; Jiangxi Provincial Key Laboratory of Preventive Medicine, School of Public Health, Nanchang University, Nanchang 330006, China. Electronic address: cxxncu@163.com.

المصدر: Pharmacological research [Pharmacol Res] 2021 Aug; Vol. 170, pp. 105734. Date of Electronic Publication: 2021 Jun 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Validation Study

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-1186 (Electronic) Linking ISSN: 10436618 NLM ISO Abbreviation: Pharmacol Res Subsets: MEDLINE

مواضيع طبية MeSH: Decision Support Techniques*, Antineoplastic Agents/*therapeutic use , Biomarkers, Tumor/*immunology , Carcinoma, Non-Small-Cell Lung/*drug therapy , Inflammation/*immunology , Lung Neoplasms/*drug therapy , Protein Kinase Inhibitors/*therapeutic use , Tumor Microenvironment/*immunology, Antineoplastic Agents/adverse effects ; Carcinoma, Non-Small-Cell Lung/enzymology ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/mortality ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Female ; Humans ; Lung Neoplasms/enzymology ; Lung Neoplasms/immunology ; Lung Neoplasms/mortality ; Male ; Predictive Value of Tests ; Progression-Free Survival ; Protein Kinase Inhibitors/adverse effects ; Reproducibility of Results ; Risk Assessment ; Risk Factors ; Time Factors